Anhui Palo Alto Pharmaceuticals, Inc.

This early-stage study tested a new nasal spray called PA9159 in 36 healthy Chinese adults. The goal was to check its safety and how the body processes it, not to treat any disease. Participants received either the spray or a placebo for up to 7 days, and researchers monitored fo…

This early-stage study tested a new asthma inhaler called PA9159 in 40 healthy adults in China. The goal was to see if it is safe and how the body processes it, not to treat asthma. Participants took single and repeated doses, and researchers monitored side effects and drug level…